$NanoVibro_老虎社区_美港股上老虎

Janess
2021-08-17

$NanoVibronix Inc(NAOV)$

Entry: $3.2-3.4

Price Target : $3.99, $4.08, $4.26, $4.44, $4.62

Stop Loss: $3 or Entry Price.

Comment:

Revenue increased 18% to $318,000, which included the first shipment of products to Ultra Pain Products, Inc. (UPPI) under its amended contract which extended terms and increased minimum purchase requirements to $8 million over three years
Launched OTC pain management device, PainShield RELIEF
Submitted request to CMS for reimbursement code(s) for UroShield and PainShield Plus
Received registration approval for UroShield from Therapeutic Goods Administration (TGA) in Australia
Balance sheet remains strong with $5.7 million in cash and $0 long-term debt as of June 30, 2021

Please like and comment below what do you think about?[害羞] [害羞]

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":833015130,"tweetId":"833015130","gmtCreate":1629189064720,"gmtModify":1629193184936,"author":{"id":3586421549867531,"idStr":"3586421549867531","authorId":3586421549867531,"authorIdStr":"3586421549867531","name":"Janess","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":73,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/NAOV\">$NanoVibronix Inc(NAOV)$</a> Entry: $3.2-3.4Price Target : $3.99, $4.08, $4.26, $4.44, $4.62Stop Loss: $3 or Entry Price. Comment: <ul>\n <li>Revenue increased 18% to $318,000, which included the first shipment of products to Ultra Pain Products, Inc. (UPPI) under its amended contract which extended terms and increased minimum purchase requirements to $8 million over three years</li>\n <li>Launched OTC pain management device, PainShield RELIEF</li>\n <li>Submitted request to CMS for reimbursement code(s) for UroShield and PainShield Plus</li>\n <li>Received registration approval for UroShield from Therapeutic Goods Administration (TGA) in Australia</li>\n <li>Balance sheet remains strong with $5.7 million in cash and $0 long-term debt as of June 30, 2021</li>\n</ul> Please like and comment below what do you think about?[害羞] [害羞] </body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/NAOV\">$NanoVibronix Inc(NAOV)$</a> Entry: $3.2-3.4Price Target : $3.99, $4.08, $4.26, $4.44, $4.62Stop Loss: $3 or Entry Price. Comment: <ul>\n <li>Revenue increased 18% to $318,000, which included the first shipment of products to Ultra Pain Products, Inc. (UPPI) under its amended contract which extended terms and increased minimum purchase requirements to $8 million over three years</li>\n <li>Launched OTC pain management device, PainShield RELIEF</li>\n <li>Submitted request to CMS for reimbursement code(s) for UroShield and PainShield Plus</li>\n <li>Received registration approval for UroShield from Therapeutic Goods Administration (TGA) in Australia</li>\n <li>Balance sheet remains strong with $5.7 million in cash and $0 long-term debt as of June 30, 2021</li>\n</ul> Please like and comment below what do you think about?[害羞] [害羞] </body></html>","text":"$NanoVibronix Inc(NAOV)$ Entry: $3.2-3.4 Price Target : $3.99, $4.08, $4.26, $4.44, $4.62 Stop Loss: $3 or Entry Price. Comment: Revenue increased 18% to $318,000, which included the first shipment of products to Ultra Pain Products, Inc. (UPPI) under its amended contract which extended terms and increased minimum purchase requirements to $8 million over three years Launched OTC pain management device, PainShield RELIEF Submitted request to CMS for reimbursement code(s) for UroShield and PainShield Plus Received registration approval for UroShield from Therapeutic Goods Administration (TGA) in Australia Balance sheet remains strong with $5.7 million in cash and $0 long-term debt as of June 30, 2021 Please like and comment below what do you think about?[害羞] [害羞]","highlighted":1,"essential":1,"paper":1,"likeSize":12,"commentSize":2,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/833015130","repostId":0,"isVote":1,"tweetType":1,"viewCount":2248,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["NAOV"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":661,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

评论（2）

热议股票